Aptevo Therapeutics Stock Technical Analysis
| APVO Stock | USD 3.82 0.23 6.41% |
As of the 2nd of March, Aptevo Therapeutics shows the Standard Deviation of 8.85, risk adjusted performance of (0.07), and Mean Deviation of 5.62. Aptevo Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Aptevo Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Aptevo, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to AptevoAptevo |
Aptevo Therapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 21.0 | Buy | 1 | Odds |
Most Aptevo analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Aptevo stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Aptevo Therapeutics, talking to its executives and customers, or listening to Aptevo conference calls.
Aptevo Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Aptevo Therapeutics Technical Analysis
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Aptevo Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Aptevo Therapeutics Trend Analysis
Use this graph to draw trend lines for Aptevo Therapeutics. You can use it to identify possible trend reversals for Aptevo Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Aptevo Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Aptevo Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Aptevo Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.08 , which may suggest that Aptevo Therapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 213.42, which is the sum of squared deviations for the predicted Aptevo Therapeutics price change compared to its average price change.About Aptevo Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Aptevo Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Aptevo Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Aptevo Therapeutics price pattern first instead of the macroeconomic environment surrounding Aptevo Therapeutics. By analyzing Aptevo Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Aptevo Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Aptevo Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2022 | 2024 | 2025 (projected) | |
| Days Sales Outstanding | 293.03 | 263.73 | 276.91 |
| PTB Ratio | 24.36 | 0.26 | 0.25 |
Aptevo Therapeutics March 2, 2025 Technical Indicators
Most technical analysis of Aptevo help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Aptevo from various momentum indicators to cycle indicators. When you analyze Aptevo charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | (1.24) | |||
| Mean Deviation | 5.62 | |||
| Coefficient Of Variation | (914.39) | |||
| Standard Deviation | 8.85 | |||
| Variance | 78.39 | |||
| Information Ratio | (0.11) | |||
| Jensen Alpha | (0.96) | |||
| Total Risk Alpha | (0.70) | |||
| Treynor Ratio | (1.25) | |||
| Maximum Drawdown | 59.06 | |||
| Value At Risk | (15.25) | |||
| Potential Upside | 9.23 | |||
| Skewness | (2.08) | |||
| Kurtosis | 8.45 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aptevo Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. To learn how to invest in Aptevo Stock, please use our How to Invest in Aptevo Therapeutics guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aptevo Therapeutics. If investors know Aptevo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aptevo Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Aptevo Therapeutics is measured differently than its book value, which is the value of Aptevo that is recorded on the company's balance sheet. Investors also form their own opinion of Aptevo Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Aptevo Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aptevo Therapeutics' market value can be influenced by many factors that don't directly affect Aptevo Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aptevo Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aptevo Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aptevo Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.